BASILICO, Annacristina
BASILICO, Annacristina
ONCOLOGIA
"Active" cancer immunotherapy by anti-Met antibody gene transfer
2008-01-01 Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met
2008-01-01 Basilico C; Arnesano A; Galluzzo M; Comoglio PM; Michieli P
A receptor-antibody hybrid hampering MET-driven metastatic spread
2021-01-01 Modica C.; Basilico C.; Chiriaco C.; Borrelli N.; Comoglio P.M.; Vigna E.
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.
2002-01-01 MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice
2004-01-01 MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
2021-01-01 Desole C.; Gallo S.; Vitacolonna A.; Vigna E.; Basilico C.; Montarolo F.; Zuppini F.; Casanova E.; Miggiano R.; Ferraris D.M.; Bertolotto A.; Comoglio P.M.; Crepaldi T.
Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer
2021-01-01 Modica C.; Olivero M.; Zuppini F.; Milan M.; Basilico C.; Vigna E.
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
2022-01-01 Martinelli I.; Modica C.; Chiriaco C.; Basilico C.; Hughes J.M.; Corso S.; Giordano S.; Comoglio P.M.; Vigna E.
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis
2008-01-01 Cassano M; Biressi S; Finan A; Benedetti L; Omes C; Boratto R; Martin F; Allegretti M; Broccoli V; Cusella De Angelis G; Comoglio PM; Basilico C; Torrente Y; Michieli P; Cossu G; Sampaolesi M
MET/HGF co-targeting in pancreatic cancer: A tool to provide insight into the tumor/stroma crosstalk
2018-01-01 Modica C.; Tortarolo D.; Comoglio P.M.; Basilico C.; Vigna E.
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody
2020-01-01 Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E.
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
1999-01-01 P. MICHIELI; C. BASILICO; S. PENNACCHIETTI; A. MAFFE'; L. TAMAGNONE; S. GIORDANO; A. BARDELLI; P.M. COMOGLIO
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy
2018-01-01 Basilico C.; Modica C.; Maione F.; Vigna E.; Comoglio P.M.
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
2004-01-01 MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
1998-01-01 BARDELLI A.; LONGATI P.; GRAMAGLIA D.; BASILICO C.; TAMAGNONE L.; GIORDANO S; BALLINARI D.; MICHIELI P.; P. COMOGLIO
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Active" cancer immunotherapy by anti-Met antibody gene transfer | 2008 | Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM | |
| A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met | 2008 | Basilico C; Arnesano A; Galluzzo M; Comoglio PM; Michieli P | |
| A receptor-antibody hybrid hampering MET-driven metastatic spread | 2021 | Modica C.; Basilico C.; Chiriaco C.; Borrelli N.; Comoglio P.M.; Vigna E. | |
| An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. | 2002 | MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO | |
| An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice | 2004 | MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P | |
| Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor | 2021 | Desole C.; Gallo S.; Vitacolonna A.; Vigna E.; Basilico C.; Montarolo F.; Zuppini F.; Casanova E.; Miggiano R.; Ferraris D.M.; Bertolotto A.; Comoglio P.M.; Crepaldi T. | |
| Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer | 2021 | Modica C.; Olivero M.; Zuppini F.; Milan M.; Basilico C.; Vigna E. | |
| hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers | 2022 | Martinelli I.; Modica C.; Chiriaco C.; Basilico C.; Hughes J.M.; Corso S.; Giordano S.; Comoglio P.M.; Vigna E. | |
| Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis | 2008 | Cassano M; Biressi S; Finan A; Benedetti L; Omes C; Boratto R; Martin F; Allegretti M; Broccoli V; Cusella De Angelis G; Comoglio PM; Basilico C; Torrente Y; Michieli P; Cossu G; Sampaolesi M | |
| MET/HGF co-targeting in pancreatic cancer: A tool to provide insight into the tumor/stroma crosstalk | 2018 | Modica C.; Tortarolo D.; Comoglio P.M.; Basilico C.; Vigna E. | |
| Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody | 2020 | Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E. | |
| Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. | 1999 | P. MICHIELI; C. BASILICO; S. PENNACCHIETTI; A. MAFFE'; L. TAMAGNONE; S. GIORDANO; A. BARDELLI; P.M. COMOGLIO | |
| Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy | 2018 | Basilico C.; Modica C.; Maione F.; Vigna E.; Comoglio P.M. | |
| Targeting the tumor and its microenvironment by a dual-function decoy Met receptor | 2004 | MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO | |
| Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth | 1998 | BARDELLI A.; LONGATI P.; GRAMAGLIA D.; BASILICO C.; TAMAGNONE L.; GIORDANO S; BALLINARI D.; MICHIELI P.; P. COMOGLIO |